Zai Lab Ltd. Announces New Restricted Share Units Grant Under 2024 Equity Incentive Plan

Reuters
05-14
Zai Lab Ltd. Announces New Restricted Share Units Grant Under 2024 Equity Incentive Plan

Zai Lab Limited, a biopharmaceutical company listed on the Hong Kong Stock Exchange and NASDAQ, has announced the grant of Restricted Share Units under its 2024 Equity Incentive Plan. On May 12, 2025, U.S. Eastern Time, the company awarded 9,800 American Depositary Shares (ADSs) to two grantees. Following this allocation, 82,686,733 shares remain available for future grants under the plan. This move is part of the company's ongoing efforts to align with its equity compensation strategy, as approved during the 2024 annual general meeting of shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zai Lab Ltd. published the original content used to generate this news brief on May 14, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10